Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis
Back
14 Apr 2024
4 p.m.
4:30 p.m.
Spotlight Stage 1 (exhibition hall)
Brad
Rovin
Spotlight Speaker
The Ohio State University
United States
Uptal
Patel
Spotlight Speaker
United States
Add to My Schedule
Rationale for anti-CD38 therapy in Lupus Nephritis
Overview of Felzartamab and current Ph1b Lupus Nephritis trial design